Skip to main content
. 2014 Jun 26;9(6):e100339. doi: 10.1371/journal.pone.0100339

Table 3. Association of rs3737884 and rs16850797 with diseases stratified by CAD or T2D status.

Additive model Unadjusted Adjusted
Comparisons MM vs. Mm vs. mma OR(95%CI)b P b OR (95%CI)c P c
rs3737884
T2D 98/62/5 1.00(reference) - 1.00(reference) -
T2D+CAD 111/57/6 1.14(0.78–1.67) 0.509 1.12(0.74–1.71) 0.587
CAD 114/53/6 1.00(reference) - 1.00(reference) -
T2D+CAD 111/57/6 0.93(0.64–1.37) 0.726 0.91(0.60–1.39) 0.655
rs16850797
T2D 8/89/63 1.00(reference) - 1.00(reference) -
T2D+CAD 28/73/73 1.22(0.88–1.703) 0.234 1.30(0.90–1.89) 0.163
CAD 13/64/96 1.00(reference) - 1.00(reference) -
T2D+CAD 28/73/73 1.62(1.19–2.22) 0.003 1.49(1.05–2.10) 0.024

CAD, coronary artery disease; T2D, type 2 diabetes; T2D+CAD, T2D with CAD; OR, odds ratios; CI, confidence interval.

a

M/m represent G/A for rs3737884, and C/G for rs16850797.

b

unadjusted for gender, age and body mass index;

c

adjusted for gender, age and body mass index. Statistical significances are considered as P≤0.05. ORs are computed using T2D or CAD as the reference group. All OR and P values are obtained by unconditional logistic regression.